A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

Recruiting

Phase 1

Phase 2

EP-104IARA Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

Sponsor:

Eupraxia Pharmaceuticals Inc.

Code:

NCT05608681

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

EP-104GI

Matching vehicle control

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-22. This information was provided to ClinicalTrials.gov by Eupraxia Pharmaceuticals Inc. on 2025-08-08.